Literature DB >> 16340795

IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.

Murielle Surquin1, Alain Le Moine, Véronique Flamand, Katia Rombaut, François-Xavier Demoor, Isabelle Salmon, Michel Goldman, Daniel Abramowicz.   

Abstract

BACKGROUND: Acute rejection of MHC class II-disparate bm12 skin grafts by C57BL/6 recipient mice is characterized by massive graft infiltration by eosinophils, together with increased intragraft amounts of IL-4 and IL-5 mRNA. IL-5 blockade prevents the intragraft eosinophil infiltration and prolongs the survival of skin allografts. As the differentiation of T cell precursors into Th2 cells is largely driven by IL-4, we investigated the role of IL-4 in MHC class II-disparate allograft rejection.
METHODS: We performed skin grafts from MHC class II incompatible bm12 mice into wild-type C57BL/6 mice (IL-4) or C57BL/6 IL-4 deficient mice (IL-4). Graft survival, in vitro T cell reactivity, and histology were compared.
RESULTS: We observed that 50% of IL-4 mice rapidly rejected their bm12 allograft, whereas the other 50% retained their graft 60 days after transplantation. Histological examination of bm12 allografts retained by IL-4 mice showed a normal appearance with no inflammatory infiltrate and no eosinophils. Among IL-4 mice that acutely rejected their bm12 skin graft, we observed a dense polymorphonuclear infiltrate. The depletion of neutrophils significantly prolonged bm12 graft survival.
CONCLUSIONS: Eosinophil infiltrates, typical of MHC class II disparate acute skin graft rejection, are critically dependent on the availability of IL-4. IL-4 mice reject MHC class II disparate skin grafts by a pathway of rejection where neutrophils play a direct causal role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340795     DOI: 10.1097/01.tp.0000176486.01697.3f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

2.  Transplantation of tail skin to study allogeneic CD4 T cell responses in mice.

Authors:  Mathias Schmaler; Maria A S Broggi; Simona W Rossi
Journal:  J Vis Exp       Date:  2014-07-25       Impact factor: 1.355

3.  Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.

Authors:  Sabina Luchetti; Kevin D Beck; Manuel D Galvan; Richard Silva; Brian J Cummings; Aileen J Anderson
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

4.  Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.

Authors:  XueDong Chen; ShiYong Zhao; XianLing Tang; HongYan Ge; Ping Liu
Journal:  Mol Vis       Date:  2011-08-11       Impact factor: 2.367

5.  The Effect of Histological CD20-Positive B Cell Infiltration in Acute Cellular Rejection on Kidney Transplant Allograft Survival.

Authors:  Yan Jiang; Rending Wang; Huiping Wang; Hongfeng Huang; Wenhan Peng; Wenxian Qiu; Jingyi Zhou; Jianghua Chen
Journal:  J Immunol Res       Date:  2016-12-12       Impact factor: 4.818

6.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

Review 7.  Graft microvascular disease in solid organ transplantation.

Authors:  Xinguo Jiang; Yon K Sung; Wen Tian; Jin Qian; Gregg L Semenza; Mark R Nicolls
Journal:  J Mol Med (Berl)       Date:  2014-06-01       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.